Screener
Chemed CHE SG&A
SG&A at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Chemed in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The source filing: Chemed’s 8-K, filed July 28, 2026. Open the filing →
- Filed
- Jul 28, 2026, 4:30 PM EDT
- Accession
- 0000019584-26-000018
FAQ
- What is Chemed's SG&A?
- Chemed (CHE) reported SG&A of $115.2M in Q2 2026.
- How has Chemed's SG&A changed year-over-year?
- Chemed's SG&A increased by 14.8% year-over-year, from $100.32M to $115.2M.
- What is the long-term trend for Chemed's SG&A?
- Over 4 years (2021 to 2025), Chemed's SG&A has grown at a 3.3% compound annual growth rate (CAGR), from $366.73M to $417.19M.
- What does SG&A mean?
- Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.
Ask your AI about Chemed's sg&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude